Overview
Rodrigo Fresco practices practicing medicine in Montevideo, Uruguay.
His clinical expertise encompasses HER2 Negative Breast Cancer, Breast Cancer, and Breast Cancer in Men.
He is actively involved in clinical research, co-authoring 13 peer reviewed articles.
Gender
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Rodrigo Fresco
Is Rodrigo Fresco a top-rated expert for HER2 Negative Breast Cancer?
MediFind is an objective health platform that identifies experts based on real-world data. Rodrigo Fresco is classified as an Experienced expert for HER2 Negative Breast Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Rodrigo Fresco participate in research or clinical trials?
Yes. Rodrigo Fresco has published 13 articles and abstracts on conditions like HER2 Negative Breast Cancer. You can view a list of Rodrigo Fresco's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Breast CancerMr. Fresco isExperienced. Learn about Breast Cancer.
- Breast Cancer in MenMr. Fresco isExperienced. Learn about Breast Cancer in Men.
- HER2 Negative Breast CancerMr. Fresco isExperienced. Learn about HER2 Negative Breast Cancer.